Inna Pharma

BiotechnologyAngelNingbo, China

Latest round

Angel

Last raised

Aug 2022

Total raised

Undisclosed

Investors

1

About Inna Pharma

Established in 2019 based in Ningbo, China, Inna Pharma is a pharmaceutical company that focuses on developing small molecule inhibitor drugs. The company focuses on the development of small molecule MyD88 inhibitors for the treatment of immune disorders such as autoimmune diseases, chronic inflammatory diseases, inflammatory tumors, ischemia-reperfusion injury, severe allergic diseases, neurodegenerative diseases, and transplant rejection.

Who invested in Inna Pharma

1 investor across 1 round

See all investors in Inna Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Aug 10, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Inna Pharma

Who invested in Inna Pharma?

Inna Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Inna Pharma raised?

Inna Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Inna Pharma last raise money?

Inna Pharma's most recent round on record is a Angel, in Aug 2022.

What does Inna Pharma do?

Established in 2019 based in Ningbo, China, Inna Pharma is a pharmaceutical company that focuses on developing small molecule inhibitor drugs.

Where is Inna Pharma headquartered?

Inna Pharma is headquartered in Ningbo, China.

Which VCs invest in companies like Inna Pharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Inna Pharma's stage. Their profiles are linked below.

Raising like Inna Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.